User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial
JMIR mHealth and uHealth · 2026
DOI: 10.2196/92981 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR mHealth and uHealth, 2026. Verfasst von Benjamin Lalani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Harvard University, Boston, MA, United States. Hauptthemen laut MEDLINE: Patient Participation, Artificial Intelligence. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Prediabetes is highly prevalent and increasing globally, yet lifestyle interventions remain underused. AI-driven mobile health (mHealth) tools can help scale diabetes prevention efforts, but the key factors driving their success are not well understood.
Objective
This post hoc secondary analysis of a randomized controlled trial (RCT) aimed to characterize the most valued features and the role of user engagement in outcomes of a fully automated mHealth intervention for diabetes prevention.
Methods
Data from 151 participants with prediabetes and overweight or obesity who were assigned to an AI-based diabetes prevention program (Sweetch) in a parent RCT (NCT05056376) were analyzed. Engagement (defined as the total number of days the app was used) was categorized into tertiles (low, medium, and high). Baseline characteristics were compared across engagement groups using ANOVA, Kruskal-Wallis, and chi-square tests, and regression models assessed the association between engagement and achievement of diabetes risk reduction outcomes (≥5% weight loss, ≥4% weight loss with ≥150 min/week of physical activity, or ≥0.2 percentage point reduction in hemoglobin A1c [HbA1c] at 12 months). Perceived usefulness of intervention features was surveyed at 12 months.
Results
Median engagement was 98 (IQR 34-232) days. Older age (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard Medical School, Harvard University, Boston, MA, United States.
- Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, United States.
- See Acknowledgments, .
ORCID-Profile: Benjamin Lalani, Gabriela Siew, Yllka Valdez, Aliyah Shehadeh, Daniel Zade, Kristin Riekert, Nestoras Mathioudakis
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
Lalani, B., Siew, G., Valdez, Y., Shehadeh, A., Zade, D., Riekert, K., Mathioudakis, N., & AI-DPP Study Group (2026). User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial. JMIR mHealth and uHealth. https://doi.org/10.2196/92981
Vancouver
Lalani B, Siew G, Valdez Y, Shehadeh A, Zade D, Riekert K, et al. User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial. JMIR mHealth and uHealth. 2026. doi:10.2196/92981
BibTeX
@article{Lalani2026,
author = {Lalani, Benjamin and Siew, Gabriela and Valdez, Yllka and Shehadeh, Aliyah and Zade, Daniel and Riekert, Kristin and Mathioudakis, Nestoras and AI-DPP Study Group, AI-DPP Study Group},
title = {User Engagement and Feature Preferences in an AI-Powered mHealth Intervention for Diabetes Prevention: Secondary Analysis of a Randomized Controlled Trial},
journal = {JMIR mHealth and uHealth},
year = {2026},
doi = {10.2196/92981}
}
EUVIMED